Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,128
Total Claims
$1.8M
Drug Cost
616
Beneficiaries
$2,961
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+62%
Opioid rate vs peers
4.0% vs 2.5% avg
+163%
Cost per patient vs peers
$2,961 vs $1,128 avg
+137%
Brand preference vs peers
19.9% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.0%
Opioid Rate
805
Opioid Claims
$20K
Opioid Cost
12.8%
Long-Acting Rate
Brand vs Generic
Brand: 3,991 claims · $1.4M
Generic: 16,075 claims · $443K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 779 | $242K |
| Vibegron | 347 | $84K |
| Etanercept | 11 | $83K |
| Semaglutide | 62 | $76K |
| Collagenase Clostridium Hist. | 33 | $60K |
| Bictegrav/Emtricit/Tenofov Ala | 12 | $48K |
| Insulin Detemir | 135 | $47K |
| Dapagliflozin Propanediol | 97 | $46K |
| Filgrastim-Aafi | 41 | $43K |
| Sitagliptin Phosphate | 70 | $37K |
| Rivaroxaban | 116 | $36K |
| Empagliflozin | 32 | $33K |
| Budesonide/Formoterol Fumarate | 75 | $32K |
| Fluticasone Propion/Salmeterol | 81 | $27K |
| Fluticasone/Umeclidin/Vilanter | 57 | $26K |
Prescribing Profile
Patient Profile
72
Avg Age
56%
Female
2.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About